Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.
Jachs M, Schwarz C, Panzer M, Binter T, Aberle SW, Hartl L, Dax K, Aigner E, Stättermayer AF, Munda P, Graziadei I, Holzmann H, Trauner M, Zoller H, Gschwantler M, Mandorfer M, Reiberger T, Ferenci P. Jachs M, et al. Among authors: hartl l. Aliment Pharmacol Ther. 2022 Jul;56(1):144-154. doi: 10.1111/apt.16945. Epub 2022 May 5. Aliment Pharmacol Ther. 2022. PMID: 35514008 Free PMC article.
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R, Schwabl P, Scheiner B, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Costa D, et al. Among authors: hartl l. J Hepatol. 2021 Apr;74(4):819-828. doi: 10.1016/j.jhep.2020.10.004. Epub 2020 Oct 16. J Hepatol. 2021. PMID: 33075344 Free article.
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes.
Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E, Bauer DJM, Paternostro R, Schwabl P, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Jachs M, et al. Among authors: hartl l. Gut. 2021 Sep;70(9):1758-1767. doi: 10.1136/gutjnl-2020-322712. Epub 2020 Nov 16. Gut. 2021. PMID: 33199442
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes.
Hartl L, Jachs M, Desbalmes C, Schaufler D, Simbrunner B, Paternostro R, Schwabl P, Bauer DJM, Semmler G, Scheiner B, Bucsics T, Eigenbauer E, Marculescu R, Szekeres T, Peck-Radosavljevic M, Kastl S, Trauner M, Mandorfer M, Reiberger T. Hartl L, et al. Hepatol Int. 2021 Oct;15(5):1160-1173. doi: 10.1007/s12072-021-10203-9. Epub 2021 May 21. Hepatol Int. 2021. PMID: 34021479 Free PMC article.
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure.
Balcar L, Semmler G, Pomej K, Simbrunner B, Bauer D, Hartl L, Jachs M, Paternostro R, Bucsics T, Pinter M, Trauner M, Mandorfer M, Reiberger T, Scheiner B. Balcar L, et al. Among authors: hartl l. United European Gastroenterol J. 2021 May;9(4):427-437. doi: 10.1002/ueg2.12089. United European Gastroenterol J. 2021. PMID: 34050619 Free PMC article.
Safety of direct oral anticoagulants in patients with advanced liver disease.
Semmler G, Pomej K, Bauer DJM, Balcar L, Simbrunner B, Binter T, Hartl L, Becker J, Pinter M, Quehenberger P, Trauner M, Mandorfer M, Lisman T, Reiberger T, Scheiner B. Semmler G, et al. Among authors: hartl l. Liver Int. 2021 Sep;41(9):2159-2170. doi: 10.1111/liv.14992. Epub 2021 Jul 10. Liver Int. 2021. PMID: 34152697 Free PMC article.
Outcomes of an HCV elimination program targeting the Viennese MSM population.
Jachs M, Binter T, Chromy D, Schalk H, Pichler K, Bauer D, Simbrunner B, Hartl L, Schmidbauer C, Mayer F, Strassl R, Mandorfer M, Gschwantler M, Reiberger T. Jachs M, et al. Among authors: hartl l. Wien Klin Wochenschr. 2021 Jul;133(13-14):635-640. doi: 10.1007/s00508-021-01898-9. Epub 2021 Jun 28. Wien Klin Wochenschr. 2021. PMID: 34181068 Free PMC article.
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.
Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Scheiner B, Schwabl P, Stättermayer AF, Pinter M, Eigenbauer E, Quehenberger P, Trauner M, Reiberger T, Mandorfer M. Jachs M, et al. Among authors: hartl l. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1362-1373.e6. doi: 10.1016/j.cgh.2021.07.012. Epub 2021 Jul 10. Clin Gastroenterol Hepatol. 2022. PMID: 34256145 Free article.
104 results